Australia, Aug. 27 -- Novozymes A.S, owns the trademark (2659440) for 'CARDIOFLOREX' till March 9, 2036.
Status: protected:
Registered/protected
Class: 5 [Cultures of microorganisms for medical purposes; cultures of microorganisms for use in dietary supplements, food supplements, vitamin and mineral preparations; dietetic substances adapted for medical use; dietetic nutrients for medical use; bacteria for use in dietary supplements contained in capsules, sachets and tablets; dietary and nutritionally fortified food products adapted for medical use; food for babies.]
Type of Mark: Word
Date of Acceptance: June 19
Registration Advertised: Aug. 26
For further details contact Plesner Advokatpartnerselskab.
The original document can be vi...